ArticlebioRxiv : the preprint server for biology2025

Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer.

Alica K Beutel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.